Xolair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Condition:   Chronic Idiopathic Urticaria Interventions:   Drug: Omalizumab Injection;   Drug: Xolair Prefilled Syringe Sponsor:   Kashiv BioSciences, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2023 Category: Research Source Type: clinical trials